Ilyang Pharmaceutical Co. said it has completed its vaccine plant with an annual egg-based production capacity of 60 million doses of influenza vaccine in Jecheon, North Chungcheong Province.
A completion ceremony was held Monday, 12 months after the ground was broken last May.
Llyang developed cell culture-based vaccines jointly with Medigen Biotechnology Corp. of Taiwan, with an aim to ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.